Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02872259
Brief Title: BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma

First Submitted : June 28, 2016
First Submitted that Met QC Criteria : August 18, 2016
First Posted : August 19, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 25, 2019
Last Update Posted : February 27, 2019